Alfred W. Sandrock, Jr., M.D., Ph.D., Joins Verge Genomics’ Board of Directors
Former Biogen R&D chief and one of the most prolific drug developers in the field…
Former Biogen R&D chief and one of the most prolific drug developers in the field…
NEW YORK–(BUSINESS WIRE)–New Residential Investment Corp. (NYSE: NRZ; “New Residential” or the “Company”) today reported…
Bigtincan, whose sales enablement automation platform helps their customers deliver “The Buying Experience of the…
Leuven, BELGIUM, Boston, MA, US – February 8, 2022 – 08.00 AM CET – Oxurion…
Press Release Nicox’s Positive FDA Meeting Shows Clear Path for NCX 4251 in Dry Eye…
Potential 6,000+ Laser Communication Terminal Opportunity through Next Decade CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – Graph Blockchain Inc. (CSE: GBLC) (OTC Pink: REGRF)…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Members will be able to leverage virtual primary care for primary care and urgent healthcare…
Transatlantic Deals Veteran Goold Joins Wilson Sonsini’s London Office From EY Wilson Sonsini’s London Office…
SoftBank to Explore Arm Public Offering SANTA CLARA, Calif. & TOKYO–(BUSINESS WIRE)–NVIDIA (NASDAQ: NVDA) and…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – February 8, 2022 Idorsia…
NEW YORK–(BUSINESS WIRE)–LIV Capital Acquisition Corp. II (the “Company”) announced today that it priced its…
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — The Board of Directors of Aleafia Health Inc….
MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly”…
SAN FRANCISCO and SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
– Dr. Beckman, a board-certified ophthalmologist, brings 30 years of experience in ophthalmology, drug development…